<DOC>
	<DOCNO>NCT02670096</DOCNO>
	<brief_summary>This single center pilot study evaluate immediate effect low-dose acetazolamide respiratory control subject treatment emergent sleep disorder breathing . The purpose study ass immediate effect one-time low-dose acetazolamide sleep breathing ( Treatment Emergent Sleep Disordered Breathing ) TE-CSA subject compare subject ' baseline evaluation without acetazolamide . Investigators also try determine immediate effect one-time low-dose acetazolamide subject ' rest ventilation ventilatory response slope compare subject ' baseline evaluation without acetazolamide .</brief_summary>
	<brief_title>A Single-center Pilot Study Evaluating Immediate Effects Low-dose Acetazolamide Respiratory Control Subjects With Treatment Emergent Sleep Disordered Breathing</brief_title>
	<detailed_description />
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Acetazolamide</mesh_term>
	<criteria>Age â‰¥18 80 year TECSA Subjects capable give informed consent Hypersensitivity acetazolamide sulfonamides Intake carbonic anhydrase inhibitor within last 72 hour Intake medication influence breathing , sleep , arousal muscle physiology CheyneStokes respiration Heart failure Renal failure Liver failure Chronic hypercapnea Hyponatremia Hypokalemia Pregnancy Breastfeeding mother Active drug/alcohol dependence abuse history</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>acetazolamide</keyword>
	<keyword>Treatment Emergent Sleep Disordered Breathing</keyword>
	<keyword>Sleep Apnea</keyword>
</DOC>